Alan S. Kadison
New York University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alan S. Kadison.
Journal of Gastrointestinal Surgery | 2000
Thomas S. Maldonado; Alan S. Kadison; Christopher A. Crisera; Juan B. Grau; Susan L. Alkasab; Michael T. Longaker; George K. Gittes
Activin, a member of the transforming growth factor-beta superfamily, has been shown to be a critical regulator in exocrine and endocrine pancreas formation. The purpose of our study was to describe the ontogeny of activin B and its inhibitor, follistatin, in developing pancreas and to elucidate potential mechanisms for exocrine and endocrine lineage selection. Mouse embryonic pancreata were dissected at various ages (day 10 [E10.5] to birth [E18.5]), sectioned, and immunostained for activin B (one of two existing isomers, A and B), follistatin, insulin, and glucagon. In addition, reverse transcriptase-polymerase chain reaction was employed to determine the messenger RNA expression of follistatin in isolated pancreatic epithelia and mesenchyme of various ages. Activin B was first detected at E12.5 in epithelial ceils coexpressing glucagon. At E16.5 th ese coexpressors appeared as clusters in close proximity to early ducts. By E18.5 activin B was localized to forming islets where cells coexpressed glucagon and were arranged in the mantle formation characteristic of mature alpha cells. Follistatin was found to be ubiquitous in pancreatic mesenchyme at early ages by immunohistochemical analysis, disappearing sometime after E12.5. Follistatin reappeared in El85 islets and remains expressed in adult islets. Follistatin messenger RNA was first detected in epithelium at E11.5, preceding its protein expression in islets later in gestation. We propose that mesenchyme-derived follistatin inhibits epithelium-derived activin at early embryonic ages allowing for unopposed exocrine differentiation and relative suppression of endocrine differentiation. At later ages the decrease in the amount of mesenchyme relative to epithelium and the subsequent drop in follistatin levels liberates epithelial activin to allow differentiation of endocrine cells to form mature islets by the time of birth.
Pediatric Surgery International | 2000
Christopher A. Crisera; J. B. Grau; Thomas S. Maldonado; Alan S. Kadison; Michael T. Longaker; George K. Gittes
Abstract We have previously suggested that the fistula tract in esophageal atresia with tracheoesophageal fistula (EA/TEF) arises from a trifurcation of the embryonic lung bud. Thus, it appears to be a respiratory-derived structure, and expresses the lung-specific transcription factor TTF-1 in its epithelium. The fistula tract does not give rise to lungs like the other branches from the bud. It grows caudally until it fistulizes with the stomach. We hypothesized that epithelial-mesenchymal interactions (EMI) dictate the differential pattern of growth of the respiratory-derived fistula tract in EA/TEF. EA/TEF was induced in rat embryos via prenatal exposure to adriamycin. Microdissection was performed on E13.5 embryos to isolate developing lung bud, fistula tract, or esophagus from adriamycin-treated or control animals, respectively. The mesenchyme and epithelium from each of these foregut structures were separated. The individual epithelia were recombined with each of the various mesenchymes and grown in culture. They were assayed for relative degrees of branching. Isolated lung-bud epithelia (LBE) or fistula epithelium were also cultured in Matrigel with exogenous fibroblast growth factors (FGF) and subsequently assayed for branching. The fistula-tract mesenchyme relatively inhibited branching of lung epithelium. The epithelium of the fistula tract could be induced to branch by non-fistula (lung or esophageal) mesenchyme. The fistula-tract and adriamycin-treated LBE both branched in response to FGF1. In contrast, neither responded to FGF7 or FGF10. EMI are defective in the developing EA/TEF. The inability to respond to FGF7 and FGF10 suggests an epithelial defect involving the receptor FGF2R-IIIb, to which these mesenchymal factors obligately bind. Thus, the mesenchyme around the developing fistula tract may lack an FGF branching morphogen(s), such as FGF1. Hence, this mesenchyme is unable to induce branching of respiratory epithelia and allows the middle branch of the embryonic tracheal trifurcation to grow caudally as an unbranched tube until it fistulizes into the stomach.
Pancreas | 2000
Thomas S. Maldonado; Christopher A. Crisera; Alan S. Kadison; Susan L. Alkasab; Michael T. Longaker; George K. Gittes
We previously showed that the undifferentiated pancreatic epithelium can differentiate into islets, ducts, or acini depending on its milieu and that laminin is necessary for pancreatic duct formation. Therefore we wanted to study the plasticity of laminin-induced duct differentiation the better to understand mechanisms of pancreatic duct lineage selection induced by basement membrane. Mouse embryonic pancreases were dissected at gestational day 11 (E11.5), and epithelium was isolated from its surrounding mesenchyme. Some epithelia were cultured in a collagen gel devoid of laminin. These epithelia were “rescued” at days 1–7 of culture by transferring them to a laminin-rich matrix (Matrigel) for 7 additional days. Other epithelia were instead first cultured in Matrigel, and then placed into collagen. Immunohistochemistry was performed for insulin, amylase, and carbonic anhydrase II. Pancreatic epithelia rescued from collagen into laminin during days 1–4 after harvest were still able to form ducts, whereas epithelia deprived of laminin for longer than this 4-day window were not. Pancreatic epithelia exposed to laminin for as little as 1 day, and then placed into collagen, still retained the ability to make ducts. Thus there is a clear cut-off in the development of the pancreatic epithelium at E11.5, after which laminin appears necessary to induce duct formation. We believe that such “windows of competence” in embryonic development imply that developmental programs in the embryo allow some flexibility.
Journal of The American College of Surgeons | 2000
Jinu Kim; Alan S. Kadison; Thomas S. Maldonado; Christopher A. Crisera; Krishna Prasadan; Pradip Manna; Barry Preuett; Mark Hembree; Michael P. Longaker; George K. Gittes
BACKGROUND/PURPOSE Retinoid signaling plays an important role in many differentiation pathways. Retinoid signaling has been implicated in the induction of differentiation by pancreatic ductal cancer cell lines and in patients with pancreatic cancer. The authors wished to better understand the role of retinoid signaling in pancreatic development. METHODS Embryonic pancreas was harvested from mice at serial gestational ages and immunohistochemical analysis was performed for retinoic acid receptors (RAR-alpha, RAR-beta, RAR-gamma), and retinoid X receptors (RXR-alpha, RXR-beta, and RXR-gamma). Also, early embryonic pancreases were cultured for 7 days with exogenous 9-cis retinoic acid (9cRA) or all-trans retinoic acid (atRA) and analyzed histologically and immunohistochemically. RESULTS Retinoid receptors were expressed in a lineage-specific distribution, with stronger expression for many in the exocrine compartment. The receptors were not often expressed until late gestation. Exogenous 9cRA induced predominantly ducts instead of acini, plus more mature endocrine (islet) architecture. Exogenous atRA induced predominantly acini instead of ducts, with no apparent endocrine effect. CONCLUSIONS Retinoids may have an important role in pancreatic differentiation, with a particular effect on secondary lineage selection between ductal and acinar phenotype. Because the control of ductal versus acinar differentiation has been implicated strongly in the pathogenesis of pancreatic ductal carcinoma, these results may lay the groundwork for studies in the mechanism of induced differentiation of pancreatic ductal cancer by retinoids.
Archive | 2001
Thomas S. Maldonado; Christopher A. Crisera; Alan S. Kadison; Michael T. Longaker; George K. Gittes
Mesenchyme is traditionally defined as a network of loosely organized mesodermal cells derived from the embryonic primitive streak with the potential to differentiate and give rise to structures such as connective tissue, blood and blood vessels, lymphatics, cartilage, muscle, bone, and stromal tissues of all glands. More recently, the mesenchyme has been found to play an increasingly sophisticated role in organogenesis through its interactions with other germ layers, specifically the endoderm. Mesenchymal-epithelial interactions have been shown to be important in the development of many organs including kidney, intestine, mammary, chick feathers, and salivary gland (1-5). The prepancreatic endoderm, originating in the duodenal anlage, requires its surrounding mesenchyme in order to differentiate into mature pancreas with acinar, ductal, and endocrine components (6-10).
Diabetes | 2000
Christopher A. Crisera; Alan S. Kadison; Gary D. Breslow; Thomas S. Maldonado; Michael T. Longaker; George K. Gittes
Differentiation | 2000
Christopher A. Crisera; Thomas S. Maldonado; Alan S. Kadison; Min Li; Susan L. Alkasab; Michael T. Longaker; George K. Gittes
Journal of Pediatric Surgery | 2001
Alan S. Kadison; Jinu Kim; Thomas S. Maldonado; Christopher A. Crisera; Krishna Prasadan; Pradip Manna; Barry Preuett; Mark Hembree; Michael T. Longaker; George K. Gittes
Journal of Surgical Research | 2000
Christopher A. Crisera; Thomas S. Maldonado; Alan S. Kadison; Min Li; Michael T. Longaker; George K. Gittes
Journal of Surgical Research | 2000
Alan S. Kadison; Thomas S. Maldonado; Christopher A. Crisera; Michael T. Longaker; George K. Gittes